AB
HAE icon

Amalgamated Bank’s Haemonetics HAE Stock Holding History

Amalgamated Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
19,750
-395
-2% -$25.4K 0.01% 960
2026
Q1 		$1.14M Buy
20,145
+390
+2% +$25.4K 0.01% 1011
2025
Q4 		$1.58M Sell
19,755
-1,386
-7% -$93.1K 0.01% 904
2025
Q3 		$1.03M Sell
21,141
-927
-4% -$57.4K 0.01% 1054
2025
Q2 		$1.65M Sell
22,068
-334
-1% -$22.1K 0.01% 860
2025
Q1 		$1.42M Sell
22,402
-578
-3% -$39.3K 0.01% 906
2024
Q4 		$1.79M Sell
22,980
-485
-2% -$39K 0.01% 837
2024
Q3 		$1.89M Sell
23,465
-1,185
-5% -$95.7K 0.02% 842
2024
Q2 		$2.04M Sell
24,650
-1,964
-7% -$173K 0.02% 832
2024
Q1 		$2.27M Sell
26,614
-5,508
-17% -$432K 0.02% 806
2023
Q4 		$2.75M Sell
32,122
-179
-0.6% -$15.5K 0.02% 787
2023
Q3 		$2.89M Sell
32,301
-643
-2% -$57.4K 0.02% 714
2023
Q2 		$2.81M Sell
32,944
-793
-2% -$67K 0.02% 735
2023
Q1 		$2.79M Sell
33,737
-2,064
-6% -$167K 0.02% 734
2022
Q4 		$2.82M Buy
35,801
+226
+0.6% +$18.2K 0.03% 763
2022
Q3 		$2.63M Buy
35,575
+916
+3% +$65.8K 0.03% 706
2022
Q2 		$2.26M Buy
34,659
+716
+2% +$42.4K 0.02% 824
2022
Q1 		$2.15M Sell
33,943
-1,603
-5% -$87.2K 0.02% 900
2021
Q4 		$1.89M Buy
35,546
+219
+0.6% +$13.3K 0.01% 970
2021
Q3 		$2.49M Sell
35,327
-3,793
-10% -$239K 0.02% 831
2021
Q2 		$2.61M Buy
39,120
+29,531
+308% +$2.09M 0.02% 851
2021
Q1 		$1.06M Sell
9,589
-670
-7% -$82.9K 0.04% 516
2020
Q4 		$1.22M Buy
10,259
+36
+0.4% +$3.88K 0.05% 424
2020
Q3 		$892K Sell
10,223
-283
-3% -$24.7K 0.04% 504
2020
Q2 		$941K Buy
10,506
+889
+9% +$89.8K 0.04% 446
2020
Q1 		$958K Sell
9,617
-530
-5% -$57.5K 0.02% 637
2019
Q4 		$1.17M Buy
10,147
+619
+6% +$74.9K 0.02% 737
2019
Q3 		$1.2M Sell
9,528
-146
-2% -$18.5K 0.03% 663
2019
Q2 		$1.16M Buy
9,674
+1,393
+17% +$137K 0.03% 686
2019
Q1 		$724K Buy
8,281
+164
+2% +$14.9K 0.02% 834
2018
Q4 		$812K Buy
8,117
+4,535
+127% +$476K 0.02% 739
2018
Q3 		$410K Sell
3,582
-5,175
-59% -$536K 0.01% 1011
2018
Q2 		$785K Buy
8,757
+1,046
+14% +$88.3K 0.02% 838
2018
Q1 		$564K Sell
7,711
-41
-0.5% -$2.81K 0.02% 897
2017
Q4 		$450K Buy
7,752
+580
+8% +$30.5K 0.01% 1039
2017
Q3 		$322K Sell
7,172
-150
-2% -$6.23K 0.01% 1168
2017
Q2 		$289K Buy
7,322
+392
+6% +$16.1K 0.01% 1216
2017
Q1 		$281K Buy
6,930
+7
+0.1% +$273 0.01% 1171
2016
Q4 		$278K Buy
6,923
+822
+13% +$31K 0.01% 1179
2016
Q3 		$221K Buy
6,101
+13
+0.2% +$446 0.01% 1206
2016
Q2 		$219K Buy
+6,088
New +$184K 0.01% 1206
2015
Q3 		– Sell
-5,341
Closed -$221K – 1329
2015
Q2 		$221K Buy
+5,341
New +$225K 0.02% 1186
2014
Q1 		– Sell
-5,295
Closed -$223K – 846
2013
Q4 		$223K Buy
+5,295
New +$218K 0.04% 715

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Amalgamated Bank's HAE Position: Q2 2026 in Review

Amalgamated Bank reduced its Haemonetics (HAE) stake by 2% in Q2 2026, selling an estimated $25.4K and leaving 19,750 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #960.

Amalgamated Bank first reported a position in HAE in Q4 2013 and has held it in 43 quarters since. The position peaked at $2.89M in Q3 2023. 146 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Amalgamated Bank held 19,750 shares of Haemonetics worth $1.48M as of Q2 2026.
  • Amalgamated Bank sold 395 Haemonetics shares in Q2 2026, an estimated $25.4K.
  • Haemonetics made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #960 holding.
  • Amalgamated Bank first reported a position in Haemonetics in Q4 2013 and has held it in 43 quarters since.
  • Amalgamated Bank's Haemonetics position peaked at $2.89M in Q3 2023.
  • 146 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.